Welcome to our blog, your go-to resource for the latest insights and trends in the life sciences industry.
Our blog is designed to provide expert guidance, practical tips, and thought leadership on key areas like medical device development, digital health, and clinical trial optimization. We cover a wide range of topics, including decentralized clinical trials (DCTs), the integration of digital health technologies (DHTs) in DCTs, and the use of Platform as a Service (PaaS) in medical device software development, to help you navigate the complex intersection of innovation and regulation. Our goal is to keep you informed and equipped with the knowledge needed to overcome industry challenges, drive innovation, and succeed in the rapidly advancing life sciences sector. Explore our blog for in-depth insights and the latest developments, and feel free to reach out if you need further assistance.
Categories:
- Clinical Research
- Cybersecurity & privacy
- Data Integrity
- Device Validation & Usability
- Digital Health
- Digital Health Technologies
- Digital health Technology
- Digital Transformation
- General
- Innovation
- Medical Device Software Development
- Quality Management
- Regulatory
- Risk-Based Quality Management
- Usability Testing
Device Fit and Classification: When “Commercial” Becomes “Clinical” (Part 3/8)
Have you validated every DHT used in your trial for analytical, clinical, and usability accuracy?
Are you certain of each device’s risk class in all deployment countries?
How do you control firmware and algorithm updates during studies?
Who in your organization owns usability validation and change control?
Would your DHT-derived endpoints survive regulatory scrutiny tomorrow?
The DHT-Ready QMS: Integrating Device, Data, and Clinical Quality into One System (Part 2/8)
Does your QMS include design-history and validation records for every DHT you use?
Are firmware, algorithms, and human-factors results governed under change control?
Can your vendor audits prove ISO 13485 and IEC 62304 compliance?
How do you integrate ALCOA++ and device traceability into your audit system?
Would your QMS withstand an FDA or MDR inspection focused on digital endpoints?
The Shockwave: What the FDA’s DHT Framework Really Means (Part 1/8)
Are your current DHTs validated for analytical, clinical, and usability accuracy?
Who in your organization owns responsibility for device version control?
Would your DHT endpoints withstand an ALCOA++ traceability audit?
Have you mapped classification and importer roles for every deployment country?
Does your QMS integrate ISO 13485 and 14971 for device-level oversight?
When a Digital Health Tool Becomes a Medical Device: The Hidden Regulatory Roles No One Told You About
If your digital health tool is already collecting endpoint data, are you absolutely sure regulators don’t see it as a medical device?
Who’s carrying the legal liability for your connected device right now—the manufacturer, the sponsor, or… you?
When your next trial audit lands, will your documentation prove compliance—or just prove confusion?
How confident are you that your “wellness app” wouldn’t trigger MDR or FDA oversight if used tomorrow in a global study?
While others are quietly securing their regulatory status, are you still assuming “we’re not a medical device company”?
The Evolution of Telemedicine and Its Impact on Medical Device Innovation
How is the rise of telemedicine reshaping the landscape of medical device innovation?
What new opportunities does telemedicine present for developing cutting-edge medical devices?
Are your medical devices ready to meet the growing demand for remote monitoring and treatment?
How can embracing telemedicine help your company expand into new markets and revenue streams?
What role does telemedicine play in enhancing patient care through innovative device solutions?